Saidi AN, Konings LAM, Dietvorst CAW, de Jong VD, et al. Assessing the effects of naltrexone-bupropion on hepatic steatosis and fibrosis in patients with T2DM and overweight or obesity: Insights from a placebo-controlled trial. Diabetes Obes Metab 2025;27:6624-6631.
PMID: 40891155